A review of the public health management of shigellosis in Australia in the era of culture-independent diagnostic testing.

Autor: Tai AY; Communicable Diseases Prevention & Control, Department of Health & Human Services, Victoria.; Infectious Diseases Department, Austin Health, Victoria., Easton M; Communicable Diseases Epidemiology & Surveillance and OzFoodNet, Department of Health & Human Services, Victoria., Encena J; Communicable Diseases Prevention & Control, Department of Health & Human Services, Victoria., Rotty J; Communicable Diseases Prevention & Control, Department of Health & Human Services, Victoria., Valcanis M; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, The University of Melbourne, Victoria., Howden BP; Infectious Diseases Department, Austin Health, Victoria.; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, The University of Melbourne, Victoria., Slota-Kan S; Communicable Diseases Prevention & Control, Department of Health & Human Services, Victoria., Gregory J; Communicable Diseases Epidemiology & Surveillance and OzFoodNet, Department of Health & Human Services, Victoria.

Publikováno v: Australian and New Zealand journal of public health [Aust N Z J Public Health] 2016 Dec; Vol. 40 (6), pp. 588-591. Date of Electronic Publication: 2016 Oct 23.

Multifunctional Pomegranate Peel Microparticles with Health-Promoting Effects for the Sustainable Development of Novel Nutraceuticals and Pharmaceuticals.

Autor: Radan, Milica, Ćujić Nikolić, Nada, Kuzmanović Nedeljković, Snežana, Mutavski, Zorana, Krgović, Nemanja, Stević, Tatjana, Marković, Smilja, Jovanović, Aleksandra, Živković, Jelena, Šavikin, Katarina

Publikováno v: Plants (2223-7747); Jan2024, Vol. 13 Issue 2, p281, 27p

Virtual high-throughput screening and simulation studies of compounds from selected traditionally important medicinal plants for the identification of potential inhibitors of AcrB.

Autor: Puzari, Minakshi, Chetia, Pankaj

Publikováno v: Journal of Biomolecular Structure & Dynamics; Jul2022, Vol. 40 Issue 10, p4451-4459, 9p

Monitoring anaphylaxis in Australia: a case in point informed by worldwide experience, driven by partnerships and collaborations.

Autor: Stiles SL; The University of Western Australia, Perth, WA, Australia.; National Allergy Strategy, Sydney, NSW, Australia., Vale SL; The University of Western Australia, Perth, WA, Australia.; National Allergy Strategy, Sydney, NSW, Australia.; Allergy & Anaphylaxis Australia, Sydney, NSW, Australia.; Australasian Society of Clinical Immunology and Allergy (ASCIA), Sydney, NSW, Australia., Salter SM; The University of Western Australia, Perth, WA, Australia.

Publikováno v: JBI evidence synthesis [JBI Evid Synth] 2022 Nov 01; Vol. 20 (11), pp. 2607-2608. Date of Electronic Publication: 2022 Nov 01.

Drug-induced anaphylaxis in Australia: we need a national drug allergy registry.

Autor: Lucas M; The University of Western Australia, Perth, WA.; Australasian Society of Clinical Immunology and Allergy, Sydney, NSW.; National Allergy Strategy, Sydney, NSW.; Sir Charles Gairdner Hospital, Perth, WA.; Perth Children's Hospital, Perth, WA., Vale S; The University of Western Australia, Perth, WA.; Australasian Society of Clinical Immunology and Allergy, Sydney, NSW.; National Allergy Strategy, Sydney, NSW.

Publikováno v: The Medical journal of Australia [Med J Aust] 2022 Jun 06; Vol. 216 (10), pp. 515-516. Date of Electronic Publication: 2022 May 14.